A Predictive Noninvasive Single-Nucleotide Variation-Based Biomarker Signature for Resectable Pancreatic Cancer: Protocol for a Prospective Validation Study.
Nico SeegerStefan GutknechtIrin ZschokkeIsabella FleischmannNadja RothJürg MetzgerMarkus WeberStefan BreitensteinLukasz Filip GrocholaPublished in: JMIR research protocols (2024)
DERR1-10.2196/54042.